N

Neurostudies, Inc. | Port Charlotte, FL

Research site

(Unclaimed)

Location

4161 Tamiami Trail Suite 201, Port Charlotte, Florida, United States of America

Site insights

Top conditions

Top treatments

Bapineuzumab

TD-9855

Droxidopa

Ozanimod

Ampreloxetine

PF-03049423

Teriflunomide

OP1

Remibrutinib

SUVN-502

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 27 total trials

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting

Early Alzheimer's Disease

Drug: Placebo

Drug: Lecanemab

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)

Enrolling

Relapsing Multiple Sclerosis

Drug: Teriflunomide

Drug: Remibrutinib

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have particip...

Enrolling

Relapsing Multiple Sclerosis

Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)

Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Locations recently updated

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic NOH in Participants with Multiple System Atrophy (CYPRESS)

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling

MSA - Multiple System Atrophy

Symptomatic Neurogenic Orthostatic Hypotension

Drug: Ampreloxetine

Drug: Placebo